Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 33535382
Mattè A, et al. (2021) Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells. Antioxidants (Basel) 10 33535382
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

Y115-p - PRDX2 (human)
Modsite: TRrLsEDyGVLktDE SwissProt Entrez-Gene
Orthologous residues
PRDX2 (human): Y115‑p, PRDX2 iso2 (human): , PRDX2 (mouse): Y115‑p, PRDX2 (rat): Y115‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, mutation of modification site
Relevant cell lines - cell types - tissues:  erythrocyte-blood
Cellular systems studied:  primary cultured cells
Species studied:  mouse

Y193-p - PRDX2 (human)
Modsite: NVDDskEyFskHN__ SwissProt Entrez-Gene
Orthologous residues
PRDX2 (human): Y193‑p, PRDX2 iso2 (human): , PRDX2 (mouse): Y193‑p, PRDX2 (rat): Y193‑p
Characterization
Methods used to characterize site in vivo 2D analysis, mass spectrometry, mass spectrometry (in vitro), phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  erythrocyte-blood
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE Syk (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE Syk (human) phospho-antibody, co-immunoprecipitation, pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
PP1, PP2 decrease
diamide increase
PP1, PP2 inhibit treatment-induced increase
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced, intracellular localization, protein conformation
Associated Diseases
Diseases Alterations Comments
sickle-cell anaemia increased